Risperdal stroke warning
Executive Summary
Johnson & Johnson schizophrenia treatment Risperdal (risperidone) adds a stroke warning to labeling. "Cerebrovascular adverse events (e.g., stroke, transient ischemic attack), including fatalities, were reported in patients (mean age 85 years; range 73-97) in trials of risperidone in elderly patients with dementia-related psychosis," labeling says. J&J is sending out a "Dear Doctor" letter on the warning...